Search clinical trials for: ABT-199

Total 6383 results

Istituto Clinico Humanitas

Recruiting

Effect of Action Observation and Motor Imagery on Arthrogenic Muscle Inhibition of the Quadriceps in Patients With End-stage Knee Gonarthrosis.

Knee Osteoarthritis | Arthrogenic Muscle Inhibitions

Italy
Philipps University Marburg Medical Center
Universität Duisburg-Essen

Completed

The Impact of Psychological Interventions on Psychometric and Immunological Measures in Patients With Major Depression

Depression

Germany
AbbVie

Completed

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

HCV Infection

United States
LanZhou University

Recruiting

Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML

Acute Myeloid Leukemia

China
PegBio Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Type 2 Diabetes Mellitus

China
Idorsia Pharmaceuticals Ltd.

Terminated

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Healthy

Germany
ALK-Abelló A/S

Completed

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

Birch Pollen Allergy

Finland, Netherlands
Centro Trattamento Integrato: Disturbi Alimentari...

Recruiting

MICBT for Non-underweight Adults With Eating Disorders (MICBT-ED)

Personality Disorders | Cognitive Dysfunction | Perfectionism | Emotion Regulation | Eating Disorders | Self Esteem | Social Interaction | Personality | Maladaptive Personality Trait | Dysfunctional Behavior, Psychology

Italy
Massachusetts General Hospital

Active, not recruiting

Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals

Depression | Obsessive Compulsive Disorder | Generalized Anxiety Disorder | Attention Deficit Hyperactivity Disorder | Trichotillomania | Panic Disorder | Social Phobia | Specific Phobia | Tourette Syndrome | Post-Traumatic Stress Disorder | Body Dysmorphic Disorder | Eating Disorder | General Medical Condition

United States
Hartford Hospital
National Institute of Mental Health (NIMH)

Completed

Stepped Care for Treating Obsessive-Compulsive Disorder

Obsessive-compulsive Disorder

United States
University of California, San Diego
Brain & Behavior Research Foundation

Completed

The Neurobiology of Approach Avoidance Training in Depression (ACTIV8)

Major Depressive Disorder

United States
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder

Somatoform Disorders | Body Dysmorphic Disorder

United States
Linkoeping University

Unknown

Cell Phone-supported Cognitive Behavioural Therapy (LINNEA)

Anxiety

Sweden
Idorsia Pharmaceuticals Ltd.

Completed

Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206

Pharmacokinetics | Pharmacodynamics | Tolerability | Safety

Netherlands
National Cancer Institute (NCI)

Active, not recruiting

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

Advanced Malignant Solid Neoplasm

United States
National Cancer Institute (NCI)

Terminated

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Epithelioid Mesothelioma | Sarcomatoid Mesothelioma | Stage IV Pleural Mesothelioma | Recurrent Malignant Mesothelioma | Stage II Pleural Mesothelioma | Stage III Pleural Mesothelioma

United States
Biogen

Terminated

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

Colorectal Cancer | Metastases

United States
Rush University Medical Center
Wayne State University

Recruiting

Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain

Back Pain | Chronic Pain | Neck Pain

United States
Ludwig Institute for Cancer Research
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen

Neoplasms

Australia
University Health Network, Toronto

Completed

Integrated Treatment for Co-occurring Eating Disorders and Posttraumatic Stress Disorder

Eating Disorder | PostTraumatic Stress Disorder

Canada
Children's Hospital of Philadelphia
National Institute of Mental Health (NIMH); Rutgers University

Completed

Comparison of Three Therapy-Based Interventions for Preventing Depression in Adolescents

Depression

United States
Affibody
Covance

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035

Psoriasis | Healthy Subjects

United Kingdom
John Sampson

Completed

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer (ERaDICATe)

Glioblastoma

United States
AbbVie (prior sponsor, Abbott)

Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Follicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid Leukemia

United States, Canada
AbbVie (prior sponsor, Abbott)

Completed

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

Rheumatoid Arthritis

Australia, Canada, Germany
AbbVie (prior sponsor, Abbott)

Completed

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Mexico
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Tel Aviv University

Completed

Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth

Anxiety Disorders

Israel
Stanford University
National Institute of Mental Health (NIMH); University of California, San Francisco

Active, not recruiting

Implementing FBT for Adolescent AN for Providers in Private Practice

Online Training for Therapists

United States
Karolinska Institutet
Region Stockholm; Forte; Stiftelsen Frimurarna Barnhuset

Active, not recruiting

Internet-delivered ACT (I-Navigator ACT) for Parents of Children With Disabilities

Depression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical Disability

Sweden
Aboca Spa Societa' Agricola
Latis S.r.l.; Fondazione Edmund Mach

Completed

ABO-GLYC in Type 2 Diabetes

Type2 Diabetes

Italy
University of Coimbra
Fundação para a Ciência e a Tecnologia

Unknown

iACT With Pain: an ICT-delivered Intervention for Self-management of Chronic Pain (iACT)

Chronic Pain
St. Joseph's Healthcare Hamilton
Ontario Mental Health Foundation

Completed

Cognitive Behavioural Therapy for Menopausal Symptoms (CBTMENO)

Menopausal Depression

Canada
University College Dublin

Completed

Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease

Inflammatory Bowel Disease

Ireland
Karolinska Institutet
Region Stockholm

Completed

Cognitive Behavioral Therapy, Guided Self Help Versus Individual Therapy

Anxiety Disorders | Major Depression | Primary Insomnia | Stress Disorders

Sweden
Florida International University
National Institute of Mental Health (NIMH)

Completed

Family and Peer Involvement in the Treatment of Anxiety Disorders in Children

Anxiety Disorders

United States
University Hospital Tuebingen

Unknown

Early Antibiotic Therapy and Vaccination

Vaccination Reaction

Germany
AbbVie
Pivotal S.L.; Laboratorio Echevarne

Completed

Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease (RAPIDA)

Moderate to Severe Crohn's Disease
AbbVie

Completed

Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

Rheumatoid Arthritis

China
AbbVie

Completed

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

Plaque Psoriasis | Nail Psoriasis
AbbVie (prior sponsor, Abbott)

Completed

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

Respiratory Syncytial Virus Infection

Japan
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Abbott
Eisai Co., Ltd.

Completed

Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis

Japan
Abbott

Completed

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis

United States, Austria, Belgium, Canada, France, Germany, Poland, Puerto Rico, Spain, Switzerland
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Adalimumab in Adult Japanese Subjects With Psoriasis

Psoriasis

Japan
Abbott

Completed

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS) (ACCESS)

Crohn's Disease

United States
Abbott

Completed

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis (ReAct)

Rheumatoid Arthritis
Abbott

Approved for marketing

Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab (PROWD)

Rheumatoid Arthritis
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Recurrent Genital Herpes Simplex Type 2

New Zealand
Abbott

Completed

Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

HCV Infection

United States

Search clinical trials for: ABT-199

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations